Kirthiha Govindaraj null, Gnanasekaran Srinivasan1 null, Kirthiha Govindaraj2 null, Ameena Mohammed3 null
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
How to cite this article: Gnanasekaran Srinivasan, Kirthiha Govindaraj, Ameena Mohammed/Prevention of Surge in Cytokines: Sjogren’s Syndrome for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy/Indian J Canc Educ Res 2022;10(2):97-100.
Pseudomyxoma peritoni is treatable with newer surgical modalities like cytoreductive surgery and hyperthermic
intraperitoneal chemotherapy (HIPEC), and the anesthetic management can be challenging. In our case, the
perioperative management was further complicated by the presence of Sjogren’s syndrome which has its own
anesthetic implications. This may be the first reported case of anesthetic management of HIPEC in a patient having
Sjogren’s syndrome along with its perioperative considerations include fluid management, stable hemodynamics,
thermoregulation, electrolyte balance, intraoperative massive fluid shifts, ventilatory management, avoidance of
renal toxicity and suppression of cytokines release plays a major role in the management in this patient.
How to cite this article: Gnanasekaran Srinivasan, Kirthiha Govindaraj, Ameena Mohammed/Prevention of Surge in Cytokines: Sjogren’s Syndrome for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy/Indian J Canc Educ Res 2022;10(2):97-100.
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
| Received | Accepted | Published |
|---|---|---|
| November 25, 2022 | December 11, 2022 | December 30, 2022 |
Friday 31 July 2026, 16:50:24 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | November 25, 2022 |
| Accepted | December 11, 2022 |
| Published | December 30, 2022 |
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.